KLIFO
Hanne Wulff Nielsen is an accomplished professional in the biotech and pharmaceutical industries, currently serving as VP of Drug Development Counselling and CMC at KLIFO A/S since February 2019. With extensive experience, Hanne has previously held roles such as Director of CMC Development Services and Business Development Lead for Sub-Saharan Africa at F. Hoffmann-La Roche, where strategic market analyses and product portfolio development were key responsibilities. Hanne's career also includes positions as Product Manager and Medical Manager at Roche, where focus areas included biologics in oncology and glioblastoma. Prior experience includes managerial roles at Orifarm Group A/S, Takeda Pharmaceuticals, and Peptech (Europe) A/S, with responsibilities spanning quality control, product development, and business development. Hanne holds a PhD in Biopharmaceutics, obtained between 1987 and 1993.
This person is not in any teams
KLIFO
KLIFO is an integrated North-European drug development consultancy with significant experience in partnering with pharmaceutical and biotech companies. We enable our partners to maximise opportunity, mitigate risks, drive innovation and achieve efficient project advancement. We offer end to end solutions across all drug development areas, including strategic project management, regulatory affairs, clinical development, clinical trial supply, quality assurance (QA), Chemistry Manufacturing and Controls (CMC) development, non-clinical development and pharmacovigilance in relation to the development of pharmaceutical products. We provide strategic advice as well as operational support in all these areas, and we partner with clients on portfolio strategies, project development strategies and project execution. KLIFO has offices in Denmark, Sweden, Germany and The Netherlands and employs more than 150 highly skilled employees.